Prof Spires-Jones chats to Lauren Pulling about synapse degeneration in Alzheimer’s, as well as the importance of mentoring in science.
Hannah Cock provides insight into the current data, controversies and pipelines for the use of cannabis-derived therapeutics in epilepsy.
The UK DRI’s COO, Adrian Ivinson, discusses the UK DRI and the current dementia care research landscape, as well as new opportunities for dementia researchers to join the Institute.
To mark International Women’s Day, we speak to neuroscientist and science communicator Samantha Yammine about her stem cell research and passion for communicating science to a wider audience.
Sara Mole (UCL) discusses her work on Batten disease, as well as the universal challenges encountered when researching and treating rare neurological diseases.
Ruth Wood, co-creator of the Honeycomb maze, describes how the new test overcomes the challenges of its predecessors, and how it can be utilized across the spectrum of neuroscience research.
Russell Kern reports on the 6-month update on the first-in-human clinical study of neural stem cells in patients with Parkinson’s disease.
In these interviews, we speak to four early career researchers whose respective research findings were highlighted by the Society as ones to watch in the coming years.
Jeff describes how dysfunction in the glymphatic system could contribute to Alzheimer’s disease, and how our growing knowledge in this area could be harnessed to develop new disease-modifying treatments.
Prof Kipnis describes his lab’s discovery that meningeal vessels directly link the brain with the lymphatic system, overturning decades of teaching that the brain lacks a direct connection to the immune system.